Effect of losartan on afferent nerve stimulation

European Journal of Pharmacology

Volumn 355, Issue 2-3, 1998, Pages 125-132

  Damase Michel, Christine ^a   Tran, Marie Antoinette ^a   Montastruc, Jean Louis ^a   Montastruc, Paul ^a  

^a INSERM   (France)

Author keywords

Afferent nerve stimulation; Arterial hypertension; Losartan; Neuropeptide Y; Noradrenaline

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; LOSARTAN; NEUROPEPTIDE Y; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOG; DRUG MECHANISM; FEMALE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE STIMULATION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; SENSORY NERVE;

EID: 0031697806     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00488-9     Document Type: Article

References (32)

1. Allen, J.M., Bircham, P.M.M., Bloom, S.R., Edwards, A.V., 1984. Release of neuropeptide Y in response to slanchnic nerve stimulation in the conscious calf. J. Physiol. 357, 401-408.
2. Baïsset, A., Montastruc, P., 1964. Inhibition de l'alcalose gazeuse de diverses réactions hypertensives expérimentales. Pathol. Biol. 12, 169-175.
3. Baïsset, A., Laporte, Y., Montastruc, P., 1959. Contribution expérimentale à l'étude des effets de l'uréthane sur les réflexes circulatoires généraux. Thérapie 14, 1053-1067.
4. Bovee, K.C., Wong, P.C., Timmermans, P.B.M.W.M., Thoolen, M.J.M.C., 1991. Effects of the non peptide Angiotensin II receptor antagonist DUP753 on blood pressure and renal functions in spontaneously hypertensive PH dogs. Am. J. Hypertens. 4, 327S-333S.
5. Clemson, B., Gaul, L., Gubin, S.S., Campsey, D.M., McConville, J., Nussberger, J., Zelis, R., 1994. Prejunctional angiotensin II receptors. J. Clin. Invest. 93, 684-691.
6. Damase-Michel, C., Tavernier, G., Giraud, P., Montastruc, J.L., Montastruc, P., Tran, M.A., 1993. Effects of clonidine, dihydralazine and splanchnic nerve stimulation on the release of neuropeptide Y, metenkephalin and catecholamines from rat adrenal medulla. Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 379-384.
7. Dray, A., Laszlo, U., Dickenson, A., 1994. Pharmacology of chronic pain. Trends Pharmacol. Sci. 15, 190-197.
8. Gaudet, E., Blanc, J., Elghozi, J.L., 1997. Restraining effects of losartan on blood pressure and heart rate variability induced by stress. Fundam. Clin. Pharmacol. 11 ((Suppl 1)), 70s-74s.
9. Goa, K.L., Wagstaff, A.J., 1996. Losartan potassium. A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 51, 820-845.
10. Goldberg, M.R., Bradstreet, T.E., Mc Williams, E.J., Tanaka, W.K., Lipert, S., Bjornsson, T.J., Waldman, S.A., Osborne, B., Pivadori, L., Lewis, G., Blum, R., Herman, T., Abraham, P.A., Halstenson, C.N., Lo, M.W., Lu, H., Spector, R., 1995. Biochemical effects of losartan, a non peptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension 25, 37-46.
11. 1 receptors in the central control of sympathetic vasomotor function. Clin. Exp. Pharmacol. Physiol. Suppl 3, S93-S98.
12. Korner, P.I., 1971. Integrative neural cardiovascular control. Physiol. Rev. 51, 312-367.
13. Laporte, Y., Montastruc, P., 1957. Role des différents types de fibres afférentes dans les réflexes circulatoires généraux d'origine cutanée. J. Physiol. (Paris) 49, 1039-1049.
14. Lundberg, J.M., Franco-Cereceda, A., Hemsen, A., Lacroix, J.S., Pernow, J., 1990. Pharmacology of noradrenaline and of neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission. Fundam. Clin. Pharmacol. 4, 373-391.
15. Messerli, F.H., Weber, M.A., Brunner, H.R., 1996. Angiotensin II receptor inhibition: a new therapeutic principle. Arch. Intern. Med. 156, 1957-1965.
16. Montastruc, P., Montastruc, J.L., Moatti, J.P., 1978. Effets du propranolol sur trois types d'hypertension expérimentale et sur l'activité rénine plasmatique chez le chien. Comparaison de l'administration intraveineuse et intracisternale. J. Pharmacol. (Paris) 9, 205-218.
17. Montastruc, J.L., Montastruc, P., Morales-Olivas, F., 1981. Potentiation by naloxone of pressor reflexes. Br. J. Pharmacol. 74, 105-109.
18. Montastruc, J.L., Dang Tran, L., 1984a. Neurohypophysal peptides and central cardiovascular control in anaesthetized dog. Clin. Exp. Hypertension Theory Practice A6 10-11, 1987-1991.
19. Montastruc, J.L., Gaillard-Plaza, G., Montastruc, P., 1984b. Naloxone suppresses the vasodepressor action of captopril in the anaesthetized dog. Clin. Exp. Hypertension Theory Practice A6 10-11, 1825-1828.
20. Montastruc, P., Dang Tran, L., Montastruc, J.L., 1985a. Reduction of the vagal pressor reflexes by neurohypophyseal peptides and related compounds. Eur. J. Pharmacol. 117, 355-361.
21. Montastruc, P., Dang-Tran, L., Carvajal, A., Rostin, M., Montastruc, J.L., 1985b. Naloxone reverses the effects of enalapril and enalaprilic acid on the pressor responses to afferent vagal stimulation. Neuropeptides 6, 537-542.
22. Montastruc, P., Damase-Michel, C., Tavernier, G., Tran, M.A., Montastruc, J.L., 1992. Release of neuropeptide Y and noradrenaline during afferent nerve stimulation. Eur. J. Pharmacol. 213, 159-162.
23. Moreau, N., Richer, C., Vincent, M.P., Giudicelli, J.F., 1993. Sympathoinhibitory effects of losartan in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 22, 126-134.
24. Niederberger, M., Aubert, J.F., Nussberger, J., Brunner, H.R., Waeber, B., 1995. Sympathetic nerve activity in conscious renal hypertensive rats treated with an agiotensin converting enzyme inhibitor or an angiotensin II antagonist. J. Hypertension 13, 439-445.
25. Noshiro, T., Shimizu, K., Way, D., Miura, Y., McGrath, B., 1994. Angiotensin II enhances norepinephrine spillover during sympathetic activation in conscious rabbits. Am. J. Physiol. 266 (Heart Circ. Physiol. 35), H1864-H1871.
26. Paintal, A.S., 1973. Vagal sensory receptors and their reflex effects. Physiol. Rev. 53, 159-227.
27. Poncet, M.F., Damase-Michel, C., Tavernier, G., Tran, M.A., Berlan, M., Montastruc, J.L., Montastruc, P., 1992. Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs. Br. J. Pharmacol. 105, 181-183.
28. Sato, A., Schmidt, R.F., 1973. Somatosympathetic reflexes: afferent fibres, central pathways, discharge characteristics. Physiol. Rev. 53, 916-947.
29. Song, K., Zhuo, J., Mendelsohn, F.A.O., 1991. Access of peripherally administered DUP753 to rat brain angiotensin II receptors. Br. J. Pharmacol. 104, 771-772.
30. Stone, C.A., Ross, C.A., Wenger, H.C., Ludden, C.A., Blessing, J.A., Totaro, J.A., Porter, C.R., 1962. Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog. J. Pharmacol. Exp. Ther. 136, 80-85.
31. Timmermans, P.B.M.W.M., Wong, P.C., Chiu, A.T., Herblin, W.F., Benfield, P., Carini, D.J., Lee, R.J., Wexler, R.R., Saye, J.A.M., Smith, R.D., 1993. Angiotensin II receptors and angiotensin receptor antagonists. Pharmacol. Rev. 45, 205-251.
32. 1 receptor antagonist irbesartan in hypertension. Hypertension 25, 22-29.